Spectral Medical Inc T.EDT

So essentially our CMO Kellum has been with us....

[SouthernTierTom]

Since 2012. First as a shareholder of Alter-cyte and more importantly as our DSMB lead screwtinizing every scrap of data from the phase 3 ( advertised Failure, but not really ) Euphrates....

Hmmmmm....

Someone should ask him, Toray, Spectral or maybe the FDA why they didnt expand on the phase 2 Euphas trial ( the one so successful they had to stop it ). Id ask an "expert" but the Euphas phase 2( 21% absolute benefit  ) does seem to fit that gut dysbiosis / culture negative / translocation tree our old leadership barked up 20 years ago.

The next time someone says, "the trial would already be done now except for this little guy"... they should just show this symbol "$"

The fact we are "playing the tax loss card" 5+ years later on the Canadien social stock media feed should help you value your 20 cent 5 FDA approval "fare-ee tale"

Bon appy and do bite down hard ;- )
Tom

[SouthernTierTom]

17 out of 18 videos are publically available from the 39th Vicenza course in Italy.  3 of the 4 EDT involved videos are also publically available ( see the website under presentation ) Where is the "Keynote lecture" the all important #18 of 18 or in our spectral specific playlist #4 of 4? Can we "selectively" share critical information and limit the dissemination of said

[JohnnyCashMoney]

You need new material 

[mercedesman]

Just Spectalating, but perhaps , in the missing video, Kellum may have elaborated on the fact (as Ronco believes), that under the right set of circumstances, PMX can be an effective therapeutic in the ongoing fight against Covid, and that the EAA might be an effective (some would argue critical) companion diagnostic for Covid patients in order rule out endotoxemia (which often leads to a deadly

[daviking]

MM/STT, You one and the same sure spend a lot of time talking to each other, here. I realize it is hard to answer yourself in your own head but PLEASE do so. OVERBURDEN! You said, "Anyway, I'm looking forward to some more information from Spectral about the potential for long term increases in revenue potential and or an increase in size of the addressable market as a result of Covid-19

[mercedesman]

Barry don't you listen? Kellum uses the Rolodex but the turning mechanism is broken - I'm hopeful that someone is coming in to look at it, and it'll be fixed very soon. Seto upgraded to the Palm Pilot 1000 so he has less concerns - at the end of the day.  It's an early version that doesn't accept any contacts with a US address, but better than nothing I suppose. What

[Domino55]

MM, is that Seto quote about 2022 from today's presentation? TIA

[mercedesman]

Yessir

[hmmmmmmmm]

Six weeks ago he said we'd be at 90 patients in December.  We'll see if they hit 30. So his word is good for what?